CSIR-NAL, Bengaluru developed non invasive ventilator for COVID-19

▴ CSIR NAL ventilator on test mode
CSIR at the forefront of innovations designed to combat the pandemic

CSIR – National Aerospace Laboratories Bangalore, a Constituent of Scientific and Industrial Research (CSIR-NAL) has developed a Non-Invasive BiPAP Ventilator in a record time of 36 days to treat COVID-19 patients.

BiPAP Non-Invasive ventilator – SwasthVayu developed by CSIR-NAL is a microcontroller-based precise closed-loop adaptive control system with a built-in biocompatible “3D printed manifold & coupler” with HEPA filter (Highly Efficient Particulate Air Filter). These unique features help to alleviate the fear of the virus spread. It has features like Spontaneous, CPAP, Timed, AUTO BIPAP modes with provision to connect Oxygen concentrator or Enrichment unit externally.


The system has been certified for safety and performance by NABL accredited agencies. The system has undergone stringent biomedical tests and beta clinical trials at NAL Health Centre.

Director NAL, Shri Jitendra J. Jadhav stated that based on global experience and specific inputs from Pulmonologist colleagues in India and abroad, NAL developed BIPAP Non Invasive Ventilator with externally connected Oxygen concentrator will be ideal to treat moderate or mid-stage severe COVID-19 patients who do not require intubation and invasive ventilation. This is ideal for treating COVID -19 patients in Wards, Make shift Hospitals, dispensaries and home in current Indian COVID 19 scenario.


The success is the culmination of efforts of a team of technocrats and medical practitioners under the leadership of Dr. CM Ananda- Head Electronics Deptt, Dr. Amarnarayan D-Chief Medical Officer-NAL, Dr. Viren Sardana–Respiratory Physiologist – IGIB and team of scientists at NAL who have worked relentlessly during Covid-19 restrictions. CSIR NAL has enabled a spin-off technology based on its expertise in the aerospace design domain.

The major advantage of this machine is, it is simple to use without any specialized nursing, cost-effective, compact and configured with the majority of indigenous components. CSIR-NAL is in process of taking it forward with the regulatory authorities for the approval and expected to get shortly. CSIR-NAL has already initiated dialogues with major public/private industries as a partner for mass production.

Recently, CSIR-CMERI, Durgapur, unveiled the COVID Protection System (COPS) for Workplace as a game-changer in the current Pandemic Scenario. Prof. (Dr.) Harish Hirani, Director, CSIR-CMERI, Durgapur, while unveiling the COPS for Workplace conglomeration of technology at a Press Conference held on 17 th July 2020, stated that “Apart from the Healthcare Workers, the frontline Security Guards of any organization are also very vulnerable to COVID through infected individuals and contaminated objects. CSIR-CMERI, Durgapur, in the near future will be developing a Digital Entry Management Systems whereby workflow would be automated and would be based upon Artificial Intelligence and the Internet of Things.

The COPS for Workplace includes contactless Solar Based Intelligent Mask Automated Dispensing Unit cum Thermal Scanner (IntelliMAST), Touchless Faucet (TouF) and 360° Car Flusher are now available for Technology Transfers and Product Orders.”Dr.Hirani further stated that “CSIR-CMERI, Durgapur, aims to support and align the Start-Ups and
Entrepreneurs while developing its technologies to give a boost to their aspirations and give them a platform to showcase their Innovative potential. CSIR-CMERI is also focused upon developing products Made in India, which will consequently boost the Atmanirbhar Bharat flagship initiative of the Government of India”.

Tags : #CSIR #CoronaInnovations #SwasthVayu #CSIR-NAL #COPS #CSIR-CMERI #NABL #NALHealthCentre #AerospaceTechnology #HEPAFilters

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

EV Conference 24---Charging Up for e-mobility Minister Ponnam Prabhakar and Jayesh Ranjan among others to graceJune 14, 2024
Are we on track to end AIDS, end viral hepatitis and end STIs by 2030?June 14, 2024
HR Conclave Focusing on Future-Forward Engineering where Engineering and Management students meet their future employees, thus exposing students to real-world HR challenges and innovative solutionsJune 14, 2024
MAGGI Empowers 10 Women to Bring their Entrepreneurial dreams to lifeJune 13, 2024
FTCCI announced its Annual Excellence Awards and invites entries, last date is 20th June 2024June 13, 2024
Bird Flu Cases by Dr Praveen Gupta, Principle Director and Chief of Neurology, Fortis Hospital.June 13, 2024
Sova Health's $1 Million Seed Funding to Drive Gut Health InnovationJune 13, 2024
The Vital Role of Early Detection: Kevin Jonas on Battling Skin CancerJune 13, 2024
Zumutor Biologics Advances Cancer Care with Novel Immunotherapy ZM008: A First-in-Class Anti LLT1 AntibodyJune 13, 2024
HP Ghosh Hospital Unveils Innovative "Chest Tree" June 12, 2024
Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, IndiaJune 12, 2024
From the frontlines: Homeless person won over alcoholism, survived floods and defeated TBJune 12, 2024
The Role of Hormones in Obesity: Why Men and Women Gain Weight DifferentlyJune 12, 2024
Silent Killer: How a Young Mother’s Vision Loss Led to a Lung Cancer DiagnosisJune 12, 2024
TruAlt Bioenergy’s subsidiary, Leafiniti Bioenergy supplies over 1000 tons of Compressed Biogas to AG&P Pratham in just 5 monthsJune 11, 2024
Southeast Asia's Most Advanced Luxury Postpartum Centre Re'Joy Suites Opens in SingaporeJune 11, 2024
Poor Muscle Health in Obesity Can be A Major Risk Factor for Early DeathJune 11, 2024
Machine Learning Uncovers How Organ Ageing Impacts Health and LongevityJune 11, 2024
Why Education is Essential for Health and LongevityJune 11, 2024
New Study Reveals Antidepressant Withdrawal Symptoms Less Common but Still SignificantJune 10, 2024